Covered
LMND · Lemonade, Inc.
Updated ·
Kill line
A daily close below $42, under the mid-$40s range held since mid-September; or a Q3 report that widens the FY2026 adjusted EBITDA loss guidance beyond $47–51 million or moves the first positive quarter into 2027.
Not a pickResearch coverage at low conviction. A medium-or-higher call would open a pick on the scoreboard.
Catalyst (1 day ago)
How picks are graded →The thesis
Lemonade's case rests on one dated promise: its first quarter of positive adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) in Q4 2026. The company confirmed on 19 October 2026 that it reports Q3 results on Thursday 5 November 2026 before the market opens, and that report decides whether the promise stands. The 26 October 2026 close of $45.08 sits 53.3% below the 52-week high of $96.57.
The business is growing fast. Q2 2026 revenue rose 79% year on year to $294.4 million, and in-force premium (the annualised premium on active policies) rose 32% to $1.434 billion, per the 29 July 2026 shareholder letter. The same letter guides Q3 to an adjusted EBITDA loss of $20–23 million, wider than the $18.7 million loss in Q2. Full-year guidance of a $47–51 million loss implies roughly $8 million of positive adjusted EBITDA in Q4.
The narrative is maturing: the AI-underwriting and profitability story is well known, and the only company news since the 13 October 2026 note is another state launch, renters insurance in Alabama on 20 October 2026. Morgan Stanley kept its Equal-Weight rating and lowered its price target to $48 on 6 October 2026. The shares have stayed in a mid-$40s range since mid-September, and the 26 October 2026 close is within 1% of the $44.71 close on 13 October 2026. Until the Q3 numbers arrive, the shares are more likely to lag the S&P 500 than to lead it.
Bullish and bearish views on Lemonade, Inc.
The bull case on Lemonade, Inc. (LMND), in brief: Losses are shrinking as revenue scales. The bear case: Q3 guidance points to a wider loss.
Bull case
- Losses are shrinking as revenue scales. The Q2 2026 adjusted EBITDA loss of $18.7 million was 54% smaller than a year earlier, on revenue up 79% to $294.4 million (shareholder letter, 29 July 2026).
- Guidance names a profitable quarter. The 29 July 2026 letter says the company continues to expect positive adjusted EBITDA in Q4 2026. Full-year guidance implies about $8 million in that quarter.
- Customer growth holds up. Customers reached 3,308,666 at the end of Q2 2026, up 23% year on year. Q3 in-force premium is guided to $1,537–1,540 million (29 July 2026 letter).
- The balance sheet funds the gap. Cash and investments stood at about $1.2 billion at the end of Q2 2026, against a quarterly net loss of $43.4 million (29 July 2026 letter).
- State launches keep coming. The company announced car insurance in Florida on 26 August 2026, renters insurance in Kansas on 1 September 2026, pet insurance in Kentucky on 22 September 2026, renters insurance in Hawaii on 6 October 2026 and renters insurance in Alabama on 20 October 2026 (company news).
Bear case
- Q3 guidance points to a wider loss. The 29 July 2026 letter guides the Q3 adjusted EBITDA loss to $20–23 million, against $18.7 million in Q2. The Q4 milestone therefore depends on a single quarter's swing.
- The loss ratio leaned on reserve releases. At the Oppenheimer conference on 12 August 2026, management attributed about 7 percentage points of the Q2 gross loss ratio of 60% to favorable prior-period development, against about 3 points of catastrophe losses.
- More risk stays on the books. The 1 July 2026 reinsurance renewal cut the quota-share cession (the share of premium and losses passed to reinsurers) from about 20% to about 18%, with catastrophe cover up to $40 million per event. The Atlantic hurricane season runs to 30 November 2026, across both Q3 and Q4.
- Analysts keep cutting targets. Morgan Stanley lowered its target to $48 on 6 October 2026 (company news feed). The $48 target is 6.5% above the 26 October 2026 close of $45.08.
- Losses remain large on a GAAP basis. The Q2 2026 GAAP net loss was $43.4 million, more than double the adjusted EBITDA loss, because adjusted EBITDA is a company-defined measure (shareholder letter, 29 July 2026).
Price setup
The 26 October 2026 close was $45.08, with a 14-day relative strength index (RSI) of 44.7, which is neither stretched nor washed out. The shares are 53.3% below the 52-week high of $96.57 and have changed by -4.9% over three months (adjusted daily closes).
The mid-$40s range has held since mid-September, with a weekly close of $49.40 on 11 September 2026 as the upper reference. The prior note named $42 as the level under that range, and the shares have not closed there in the period covered by the adjusted daily closes. The Q3 report on 5 November 2026 is the event most likely to move the shares out of the range in either direction.
Crowding evidence is mixed. The earnings date is 10 days away. The last short-interest reading cited in earlier coverage was 17.05% of float on 3 June 2026, and no newer figure is confirmed here. The shares sit far below their high with no wide gap above a rising moving average, so price-based crowding is low.
Catalysts, next 30 days
- It tests the $20–23 million adjusted EBITDA loss guidance, the loss ratio with less reserve release, and whether positive Q4 adjusted EBITDA is reaffirmed.
- 30 November 2026: The Atlantic hurricane season ends, closing the main catastrophe-loss window for Q4.
Elapsed catalysts
- 4 November 2026, 8:00 am ET: The shareholder question platform closes to upvotes. The company opened it on 28 October 2026 (per the company's 19 October 2026 announcement and web reports), and the top questions often shape the call. (passed 2d ago)
What would change the view
The case breaks if the Q3 report widens the FY2026 adjusted EBITDA loss guidance beyond $47–51 million, moves the first positive quarter into 2027, or shows a Q3 loss wider than $23 million. A Q3 gross loss ratio well above 60% with little favorable prior-period development would also weaken it. A daily close below $42, under the mid-$40s range, would end the case on price.
The case strengthens if Q3 lands inside the $20–23 million loss guidance, the loss ratio holds near 60% without a large reserve release, and management reaffirms positive Q4 adjusted EBITDA. That outcome would be new evidence and would be weighed as such.
What it trades with
Lemonade trades as a high-growth insurance technology company and moves with other unprofitable growth shares and with small and mid-cap insurers on catastrophe news. Hurricane activity before 30 November 2026 and changes in reinsurance pricing affect its results directly. No current theme cluster carries the name, so its price follows its own earnings milestones more than any group.
Notes
- Lemonade announced on 29 July 2026 that Nick Stead becomes chief financial officer on 1 January 2027, when Tim Bixby moves to the board.
- The reinsurance renewal effective 1 July 2026 cut quota-share cession to about 18% from about 20%, so Lemonade retains a larger share of its underwriting risk.
- Adjusted EBITDA is a company-defined, non-GAAP measure; Lemonade reported a Q2 2026 GAAP net loss of $43.4 million alongside an $18.7 million adjusted EBITDA loss.